Class information for:
Level 1: ORAL CHEMOTHERAPY//ORAL ANTICANCER AGENTS//ORAL ANTICANCER DRUGS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
29417 153 29.0 59%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3031 2012 THIOPURINE METHYLTRANSFERASE//6 MERCAPTOPURINE//THIOPURINE S METHYLTRANSFERASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ORAL CHEMOTHERAPY Author keyword 8 21% 23% 35
2 ORAL ANTICANCER AGENTS Author keyword 2 44% 3% 4
3 ORAL ANTICANCER DRUGS Author keyword 2 44% 3% 4
4 ORAL ANTICANCER AGENT Author keyword 2 67% 1% 2
5 MEDICARE PRESCRIPTION DRUG IMPROVEMENT AND MODERNIZATION ACT Author keyword 2 50% 2% 3
6 ORAL ANTINEOPLASTIC AGENTS Author keyword 1 100% 1% 2
7 ADULT AMBULATORY SERV Address 1 50% 1% 1
8 BASIC TREATMENT EQUIVALENT BTE Author keyword 1 50% 1% 1
9 CANCER INDICATORS Author keyword 1 50% 1% 1
10 CARE TRANSFER Author keyword 1 50% 1% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ORAL CHEMOTHERAPY 8 21% 23% 35 Search ORAL+CHEMOTHERAPY Search ORAL+CHEMOTHERAPY
2 ORAL ANTICANCER AGENTS 2 44% 3% 4 Search ORAL+ANTICANCER+AGENTS Search ORAL+ANTICANCER+AGENTS
3 ORAL ANTICANCER DRUGS 2 44% 3% 4 Search ORAL+ANTICANCER+DRUGS Search ORAL+ANTICANCER+DRUGS
4 ORAL ANTICANCER AGENT 2 67% 1% 2 Search ORAL+ANTICANCER+AGENT Search ORAL+ANTICANCER+AGENT
5 MEDICARE PRESCRIPTION DRUG IMPROVEMENT AND MODERNIZATION ACT 2 50% 2% 3 Search MEDICARE+PRESCRIPTION+DRUG+IMPROVEMENT+AND+MODERNIZATION+ACT Search MEDICARE+PRESCRIPTION+DRUG+IMPROVEMENT+AND+MODERNIZATION+ACT
6 ORAL ANTINEOPLASTIC AGENTS 1 100% 1% 2 Search ORAL+ANTINEOPLASTIC+AGENTS Search ORAL+ANTINEOPLASTIC+AGENTS
7 BASIC TREATMENT EQUIVALENT BTE 1 50% 1% 1 Search BASIC+TREATMENT+EQUIVALENT+BTE Search BASIC+TREATMENT+EQUIVALENT+BTE
8 CANCER INDICATORS 1 50% 1% 1 Search CANCER+INDICATORS Search CANCER+INDICATORS
9 CARE TRANSFER 1 50% 1% 1 Search CARE+TRANSFER Search CARE+TRANSFER
10 DEFERRALS 1 50% 1% 1 Search DEFERRALS Search DEFERRALS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PRESCRIPTION DRUG IMPROVEMENT 1 100% 1% 2
2 CHEMOTHERAPY TREATMENT 1 19% 3% 5
3 ADMINISTERED CHEMOTHERAPY 1 50% 1% 1
4 CANCER PREVENTION TRIALS 1 50% 1% 1
5 COMBINATION SEQUENTIAL CHEMOTHERAPY 1 50% 1% 1
6 PILL COUNTS 1 12% 3% 5
7 MODERNIZATION ACT 1 25% 1% 2
8 FINANCIAL TOXICITY 0 33% 1% 1
9 ORAL CHEMOTHERAPY 0 11% 2% 3
10 COMMON TERMINOLOGY CRITERIA 0 11% 1% 1

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Adherence enhancing interventions for oral anticancer agents: A systematic review 2014 9 17 59%
A review on adherence management in patients on oral cancer therapies 2012 19 42 24%
Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review 2013 17 52 17%
Adherence to oral antineoplastic agents by cancer patients: definition and literature review 2014 4 39 28%
Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents 2012 7 51 31%
Improving Adherence to Oral Cancer Therapy in Clinical Practice 2014 3 46 22%
Oral administration of antineoplastic agents: the challenges for healthcare professionals 2015 0 23 65%
Anticancer oral therapy: Emerging related issues 2010 33 70 9%
Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients 2015 0 29 28%
Interventions for adherence with oral chemotherapy in hematological malignancies: A systematic review 2015 0 26 27%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ADULT AMBULATORY SERV 1 50% 0.7% 1
2 CLIN PHARM PRACTICE SOCIAL SCI 1 50% 0.7% 1
3 OSPED SG MOSCATI 1 50% 0.7% 1
4 PLUMMER LIB 1 50% 0.7% 1
5 PSYCHOL HLTH TEAM 1 50% 0.7% 1
6 REG CANC UPPSALA OREBRO REG 1 50% 0.7% 1
7 SERV PSYCHIAT ADULTES PSYCHOL MED 1 50% 0.7% 1
8 STUDIES PHARMACEUT CARE CEATENF 1 50% 0.7% 1
9 LA MADDALENA CLIN CANC 1 19% 2.0% 3
10 CIE 3 0 33% 0.7% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000157297 OXALIPLATIN//CAPECITABINE//IRINOTECAN
2 0.0000144099 MEDICATION ADHERENCE//PATIENT COMPLIANCE//MORISKY SCALE
3 0.0000141073 AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE
4 0.0000107880 CARDIOVASC METABOL SERV//FORMULARY DEV//SPECIALTY DRUGS
5 0.0000086074 CANC INFORMAT SERV//OFF CANC INFORMAT SERV//PRIMROSE ONCOL UNIT
6 0.0000079752 ANTINEOPLASTIC DRUGS//TOXICITY ENVIRONMENTAL//HAZARDOUS DRUGS
7 0.0000079172 POTENTIAL DRUG DRUG INTERACTION//POTENTIAL DRUG DRUG INTERACTIONS//PRESCRIPTIONS SCREENING
8 0.0000075434 CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB
9 0.0000073938 METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL
10 0.0000073883 HLTH SERV ECON BRANCH//FINANCIAL TOXICITY//OUT OF POCKET COSTS